Patents by Inventor Soumik BasuRay

Soumik BasuRay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections
    Patent number: 12298305
    Abstract: In one embodiment, the invention provides a method of diagnosing sepsis or a virus-related infection (often a viral hemorrhagic fever infection) in a subject by detecting and measuring the level of a set of sepsis and virus infection-associated-GTPase biomarkers in a sample obtained from the subject using multiplexed flow cytometry. Related kits are also provided. In a preferred embodiment, the invention provides point of care diagnostic methods for determining an early stage sepsis or the severity of a virus infection, especially in a hospital or other setting.
    Type: Grant
    Filed: February 23, 2021
    Date of Patent: May 13, 2025
    Assignee: UNM RAINFOREST INNOVATIONS
    Inventors: Tione Buranda, Jacob Ongudi Agola, Soumik BasuRay, Scarlett Swanson, Angela Wandinger-Ness, Peter C. Simons, Virginie Bondu
  • Activated GTPase-Based Assays and Kits for the Diagnosis of Sepsis and Other Infections
    Publication number: 20210325392
    Abstract: In one embodiment, the invention provides a method of diagnosing sepsis or a virus-related infection (often a viral hemorrhagic fever infection) in a subject by detecting and measuring the level of a set of sepsis and virus infection-associated-GTPase biomarkers in a sample obtained from the subject using multiplexed flow cytometry. Related kits are also provided. In a preferred embodiment, the invention provides point of care diagnostic methods for determining an early stage sepsis or the severity of a virus infection, especially in a hospital or other setting.
    Type: Application
    Filed: February 23, 2021
    Publication date: October 21, 2021
    Inventors: Tione Buranda, Jacob Ongudi Agola, Soumik BasuRay, Scarlett Swanson, Angela Wandinger-Ness, Peter C. Simons, Virginie Bondu
  • Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections
    Patent number: 10962541
    Abstract: In one embodiment, the invention provides a method of diagnosing sepsis or a virus-related infection (often a viral hemorrhagic fever infection) in a subject by detecting and measuring the level of a set of sepsis and virus infection-associated-GTPase biomarkers in a sample obtained from the subject using multiplexed flow cytometry. Related kits are also provided. In a preferred embodiment, the invention provides point of care diagnostic methods for determining an early stage sepsis or the severity of a virus infection, especially in a hospital or other setting.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: March 30, 2021
    Assignee: UNM Rainforest Innovations
    Inventors: Tione Buranda, Jacob Ongudi Agola, Soumik BasuRay, Scarlett Swanson, Angela Wandinger-Ness, Peter C. Simons, Virginie Bondu
  • Activated GTPase-Based Assays and Kits for the Diagnosis of Sepsis and Other Infections
    Publication number: 20190242897
    Abstract: In one embodiment, the invention provides a method of diagnosing sepsis or a virus-related infection (often a viral hemorrhagic fever infection) in a subject by detecting and measuring the level of a set of sepsis and virus infection-associated-GTPase biomarkers in a sample obtained from the subject using multiplexed flow cytometry. Related kits are also provided. In a preferred embodiment, the invention provides point of care diagnostic methods for determining an early stage sepsis or the severity of a virus infection, especially in a hospital or other setting.
    Type: Application
    Filed: February 7, 2019
    Publication date: August 8, 2019
    Inventors: Tione Buranda, Jacob Ongudi Agola, Soumik BasuRay, Scarlett Swanson, Angela Wandinger-Ness, Peter C. Simons, Virginie Bondu
  • Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections
    Patent number: 10261084
    Abstract: In one embodiment, the invention provides a method of diagnosing sepsis or a virus-related infection (often a viral hemorrhagic fever infection) in a subject by detecting and measuring the level of a set of sepsis and virus infection-associated-GTPase biomarkers in a sample obtained from the subject using multiplexed flow cytometry. Related kits are also provided. In a preferred embodiment, the invention provides point of care diagnostic methods for determining an early stage sepsis or the severity of a virus infection, especially in a hospital or other setting.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: April 16, 2019
    Inventors: Tione Buranda, Jacob Ongudi Agola, Soumik BasuRay, Scarlett Swanson, Angela Wandinger-Ness, Peter C. Simons, Virginie Bondu